TMO:NYSEThermo Fisher Scientific Inc Analysis
Data as of 2026-09-01 - not real-time
$600.50
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind Thermo Fisher Scientific Inc. is bullish at $600.50, with short-term averages leading the long-term ones. Across the trailing 30 sessions it gained 14.7%. RSI sits at 52.3, which reads as neutral, and MACD momentum is bearish. Watch $564.40 as support and $647.00 as the nearer resistance level.
The shares look fair, trading on 32.3 times earnings in line with a sector average of 30.6. The average analyst target implies 5.1% above today's level. Revenue is growing at 10.5% on a 15.0% profit margin. The 0.30% dividend yield looks covered by current payout levels.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 33.3%, a beta of 0.59 and a maximum drawdown of 31.5%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons line up on buy — conviction 5 out of 10.
The shares look fair, trading on 32.3 times earnings in line with a sector average of 30.6. The average analyst target implies 5.1% above today's level. Revenue is growing at 10.5% on a 15.0% profit margin. The 0.30% dividend yield looks covered by current payout levels.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 33.3%, a beta of 0.59 and a maximum drawdown of 31.5%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons line up on buy — conviction 5 out of 10.
Top Market Events
Thermo Fisher Scientific NYSE:TMO has been selected by ImmuPharma as the key drug product and contract development...Thermo Fisher Scientific Inc. NYSE:TMO and Danaher Corporation NYSE:DHR are two of the world’s largest life sciences...Life sciences company Thermo Fisher NYSE:TMO announced in Q2 CY2026, with sales up 10.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 535.50
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 32.3 versus sector average of 30.6
- Trading above the 200-day average of 535.50
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 32.3 versus sector average of 30.6
- Analyst targets imply +5.1% versus the current price
- Profit margin of 15.0% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth10.50%
Profit Margin15.04%
P/E Ratio32.3
ROE13.51%
ROA5.13%
Debt/Equity80.58
P/B Ratio4.2
Op. Cash Flow$9.0B
Free Cash Flow$6.2B
Industry P/E30.6
Technical Analysis
TrendBullish
RSI52.3
Support$564.40
Resistance$647.00
MA 20$607.49
MA 50$563.26
MA 200$535.50
MACDBearish
VolumeStable
Fear & Greed Index92.25
Valuation
Fair Value$228.76
Target Price$631.42
Upside/Downside5.15%
GradeFair
TypeGrowth
Dividend Yield0.30%
Risk Assessment
Beta0.59
Volatility33.30%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.